BPC-157 vs GHK-Cu: Differences in Evidence, Status and Regulation
BPC-157 and GHK-Cu are compared below on structure, research stage, registered clinical studies, and regulatory status, using the same sourced data shown on each entry page. This comparison is descriptive and does not rank either peptide.
Comparison table
| Dimension | BPC-157 | GHK-Cu |
|---|---|---|
| Category | Tissue repair (research) | Cosmetic |
| Research status | Research only | Cosmetic ingredient |
| Origin | No data | No data |
| Amino acids | 15 | No data |
| Molecular weight | No data | No data |
| Overall evidence level | No data | No data |
| Human evidence rows in our table | No data | No data |
| Registered studies (ClinicalTrials.gov) | 3 | 2 |
| Most advanced registered phase | Phase 2 | Phase 2 |
| Half-life (sourced) | No data | No data |
| Status: United States | No data | No data |
| Status: European Union | No data | No data |
| Status: United Kingdom | No data | No data |
| Status: WADA (sport) | No data | No data |
Key differences
- BPC-157 is classified here as Tissue repair (research); GHK-Cu as Cosmetic.
- Research status differs: BPC-157 is listed as "Research only" and GHK-Cu as "Cosmetic ingredient".
- ClinicalTrials.gov lists 3 registered studies matching BPC-157 and 2 matching GHK-Cu.
Entry pages
Full sources, evidence tables, and regulatory details are on each entry page: BPC-157 and GHK-Cu.
This comparison does not rank the two peptides and does not suggest that either one is appropriate for any use.